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Abstract
We propose a new approach for clustering DNA features using array CGH data from
multiple tumor samples. We distinguish data-collapsing: joining contiguous DNA clones
or probes with extremely similar data into regions, from clustering: joining contiguous,
correlated regions based on a maximum likelihood principle. The model-based cluster-
ing algorithm accounts for the apparent spatial patterns in the data. We evaluate the
randomness of the clustering result by a cluster stability score in combination with cross-
validation. Moreover, we argue that the clustering really captures spatial genomic de-
pendency by showing that coincidental clustering of independent regions is very unlikely.
Using the region and cluster information, we combine testing of these for association with
a clinical variable in an hierarchical multiple testing approach. This allows for interpret-
ing the significance of both regions and clusters while controlling the Family-Wise Error
Rate simultaneously. We prove that in the context of permutation tests and permutation-
invariant clusters it is allowed to perform clustering and testing on the same data set.
Our procedures are illustrated on two cancer data sets.
Introduction
Array Comparative Genomic Hybridization (array CGH) was designed as a high-resolution
measurement device for copy number aberrations, which are known to be involved in the
cancer development process (Kallioniemi, 2008). Through hybridization, fluorescent labeled
DNA is extracted from test and reference samples resulting in log-ratios of intensities of the
two types of samples. When plotted against chromosomal position, the log-ratio data appears
as segments at various amplitudes. One is particularly interested in those chromosomal
segments which show levels of loss or gain, because those segments may possibly harbor
oncogenic genes, cancer progression markers or other relevant features. Array CGH data is
often encoded as loss (deletion), normal and gain by assigning discrete copy number states
to chromosomal segments. Generally, two processing steps are performed for this purpose:
segmentation and calling.
Segmentation denotes a process to find breakpoints from single copy number profiles.
Many segmentation algorithms have been proposed. Willenbrock and Fridlyand (2005); Lai
et al. (2005) discuss and compare several of those, while Dı`az-Uriarte and Rueda (2007)
provide software to simultaneously apply several popular algorithms to the same data set.
Recently, new algorithms have been introduced to deal with the computational burden caused
by the increasing resolution of the arrays (f.e. Pique-Regi et al., 2008). After segmentation,
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assigning discrete states to the segmented data is referred to as calling (Van de Wiel et al.,
2006).
Here, we will assume that the data has been properly segmented and discretized. While
the measurement unit is clearly defined from the array platform used, there is no a priori
biologically most relevant unit of interest in DNA copy number experiments. This contrasts
the majority of mRNA experiments, for which the genes as coding regions for proteins are
a natural relevant unit. By nature, the crucial DNA copy number events, aberrations, arise
when a piece of DNA is either deleted or gained. Such a piece can be an entire chromosomal
arm, but also just 1/106th of an arm. Therefore, we aim to learn the relevant units from
the data. Such units are particularly important for interpretation and power when testing
association with clinical data. For simplifying terminology, we refer to the array CGH features
as probes although this could also reflect clones or cDNAs. Then, our proposed two-step
dimension reduction approach enables one to consider the data at two levels with decreasing
resolution: regions and clusters. The regions are the result of collapsing neighboring probes of
which the discretized values are highly repetitious and redundant within (almost) all profiles
(Van de Wiel and Van Wieringen, 2007), while the clusters contain contiguous similarly
behaving regions.
After collapsing, our study proceeds in two directions. First, we develop a model-based
clustering algorithm that considers spatial patterns. Second, we perform simultaneous region-
wise and cluster-wise multiple testing. The idea of multiple testing based on clustered results
is not new. Benjamini and Heller (2007) adapt the False Discovery Rate (FDR) to allow
for cluster-level multiple testing in the analysis of functional Magnetic Resonance Imaging
(fMRI) data. Moreover, comparing to voxel-wise (feature level) multiple testing, they asserted
that their method improved SNR (signal to noise ratio) and gained statistical power. Even
though both array CGH data and fMRI data have strong spatial correlation patterns, we
cannot apply the methodology of Benjamini and Heller (2007) directly. Using fMRI it is
often feasible to obtain the clusters of voxels from independent, preparatory scans. In array
CGH data, however, it is hardly possible to obtain such information a priori. One solution
is splitting the set of samples in two parts, where one is used for clustering and the other
for testing, which guarantees independence between clustering and testing. However, in that
case, we should accept significant power loss due to splitting. Perone Pacifico et al. (2004)
offer an alternative solution, also in the context of imaging data and FDR: clustering on the
basis of p-values. Their theory is based on smooth Gaussian random fields, which is not a
realistic model for array CGH data. Moreover, this would render meaningful clusters from a
testing perspective only.
We show that, in the context of permutation testing and family-wise error rate (FWER),
it is possible to apply both clustering and testing to the same data set if the cluster result
is permutation invariant. We consider selection of a suitable test statistic on both levels
(regions and clusters) and use an hierarchical testing procedure to control the FWER. The
entire clustering plus testing procedure is illustrated on two array CGH cancer data sets.
High-dimensionality
High-dimensionality is a common theme for the analysis of data produced by high-throughput
genomic technologies. It denotes the situation that the number of features is much larger than
the number of samples. Due to the large dimension, traditional multiple testing procedures
such as Bonferroni yield very conservative results.
While the term ‘high-dimensionality’ is used neutrally in terms of the number of features,
some authors note that technological developments in data generating processes can allow a
more specific approach for the data. Benjamini and Heller (2007) suggest that the assumption
of infinitely many elements in a cluster is not unrealistic for fMRI data in an environment of
improved technical resolution. A similar development has occurred for our type of genomic
data. Here, the resolution increased from chromosome arms (∼ 40) to Bacterial Artificial
Clones (∼ 3000), to oligos (< 400, 000), to next generation arrays (> 1, 000, 000) (Park,
2008). The increasing number of features does not necessarily imply an increasing number
of ‘distinct’ relevant units, because these new features may appear as repetitions of similar
copies on a coarser scale.
We briefly illustrate the above idea. Consider the extreme case in which a certain region
of the genome spanning r probes never contains a genomic breakpoint for the type of samples
under study. Doubling the resolution in this genomic region to 2r will only lead to measuring
more of the same (due the absence of a breakpoint) and hence for both resolutions the relevant
unit can be collapsed to one data point per sample for this genomic region.
Discretized array CGH data usually appears as large numbers of distinct blocks which
consist of probe vectors with (almost) the same discretized status (across samples) for as
many as hundreds or thousands of probes. So, regions in the data correspond to distinct
blocks. Those regions may be considered as biologically relevant units for the type of samples
under study.
Collapsing repetitious probes is useful, since it reduces unnecessary dimension of data and
enhances computational convenience. Conventional clustering methods using correlational
association among probes seem not appropriate in this stage, because these may yield mingled
clusters: repetitiously copied probes mixed with similarly behaving probes. Hence this may
weaken the performance and interpretation of the clustering methods usually performed in
the next stage. From this point of view, it is desirable to separate two procedures: collapsing
and clustering. The first step handles the technical resolution and is used for dimension
reduction. The latter step is applied for combining similar behaving probe regions so that
one may obtain hints of collective behaviors within certain genomic neighborhoods.
We do not suggest a new algorithm for the collapsing process, but instead use the one
proposed by Van de Wiel and Van Wieringen (2007). Here, the relative amount of information
lost by collapsing can be controlled; we use 0.5% as an upper bound. Note that this algorithm
maintains the high resolution where desired: small genomic segments that differ consequently
from their neighbors are kept. In construction of the clustering models, we incorporate the
collapsing information into our model in two ways: either via base-pair distance between two
regions or via the number of collapsed probes between two regions.
Methods
Mathematical setting
In this paper, the overall statistical model corresponds to n i.i.d. copies of a pair of random
variables denoted by (X1, Y 1), ..., (Xn, Y n), where, for each individual i = 1, ..., n, Xi ∈
{0,−1, 1}m is the state vector along all the (ordered) regions and Y i ∈ {0, 1} is a label
determining which group the individual belongs to. In this model X = (X1, ...,Xn) is a
sample of i.i.d. variables, in which the distribution of Xi can be seen as a mixture between
the two groups Y i = 0 and Y i = 1. In particular, note that the distribution of the Xi’s does
not involve the relationship between the Y i’s and the Xi’s.
In a nutshell, our approach firstly clusters the rows of X that are similar from a model-
based point of view and secondly detects the regions and clusters that are significantly asso-
ciated to the label vector Y = (Y 1, ..., Y n):
• The clustering phase uses the variables X, by assuming a specific parametric model for
the distribution of the Xi’s . Since X1, ...,Xn are i.i.d., the clustering result Â(X) is
invariant under permutations of the columns of X.
• The testing phase tests the independence between regions X1:nj = (X
i
j)1≤i≤n and Y
and between clusters (X1:nj )j∈A and Y , conditional on the clustering Â(X). The (con-
ditional) p-values are computed by performing permutations of the observed labels,
which is valid because Â(X) is permutation invariant. Then, these p-values are inte-
grated in an hierarchical multiple testing procedure controlling the family-wise error
rate both on the region and cluster level.
Clustering model
Our motivation for spatial clustering comes from Figure 1. In Figure 1, we illustrate Kendall
correlations for pairs of all regions for two discretized array CGH data sets. Strong correlations
are concentrated in the diagonal parts, so spatial dependency patterns are notably block-
wise structures. Such correlations are caused by a high likelihood of the same aberration to
span multiple consecutive regions (as opposed to off-diagonal correlations between regions on
different chromosomes, which necessarily represent different aberrations). We incorporate the
spatial correlation in our modeling approach. Log-linear models are a natural candidate for
describing discrete data. Hence, we apply such models for our purpose, while adapting these
to take specific data characteristics such as spatial correlations, but also physical base pair
distance between regions, into account. Moreover, we consider practical concerns for efficient
optimization of the clustering.
Letm be the number of regions and n be the number of i.i.d. samples under consideration.
Moreover, let each region be indexed by its spatial location on the DNA, that is, the (j−1)-th
and (j +1)-th regions are the neighbors of the j-th region. The goal is to identify clusters so
that regions in one cluster behave similarly.
We first consider the quadratic exponential model (Cox and Wermuth, 1994) which ap-
proximates log-linear models for binary data up to 2nd order interactions. In our case we
consider trinary valued variables. Because the samples are initially assumed i.i.d., we suppress
the sample index when describing the model, so Xj = xj refers to the observed state of the
jth region. Hence, for observations xA = (xj)j∈A, with xj ∈ {0,−1, 1} and A ⊂ {1, . . . ,m},
the marginal distribution of the corresponding random variable XA, pA, is modeled as
log pA(xA) = αA +
∑
j∈A
βA,jxj +
∑
j<k, j,k∈A
γA,jkf(xj, xk),
where f(xj, xk) = −1, if xj 6= xk and f(xj, xk) = xjxk, otherwise. Note that αA is not a
free parameter, because it is determined by the ‘summing-to-one’ condition. The discrete
values ‘0’, ‘−1’ and ‘1’ denote normal (= 2 copies), loss (< 2 copies) and gain (> 2 copies),
respectively. We do not consider amplification (high copy number gain) and double deletion
Figure 1: Two correlation (Kendall’s τ) heatmaps for Chin et al. (2006) (left) and Douglas
et al. (2004) (right) data sets. Data sets contain 383 and 436 regions, respectively. Regions
are plotted according to chromosomal position. Colors represent correlations from -1 (cyan)
to 1 (pink).
(0 copies) as separate states because of computational complexity of the clustering algorithm,
but alternative solutions to accommodate such different states are discussed in the Discussion.
Since our purpose is not to specify every 2nd order interaction γA,jk, but to bind features
which are in the same cluster, it may be better to simplify the above model by assigning one
average 2nd order interaction per cluster. Since in actual array CGH data we observe physical
base-pair distance between two regions, we use this information in the model. We assume the
dependence of two regions becomes weaker for more distant pairs of regions (similar to p.430
of Cressie (1993)). Hence the interaction parameter γA,jk is represented as γAd˜jk and
d˜jk =
{
d−qjk /max{d
−q
jk } if j and k are in the same chromosome,
0 otherwise.
where djk is the base-pair distance between two regions j and k and the maximum is computed
over pairs in the same chromosome. Alternatively, the distance function can be used to
incorporate the collapsing information; for example, the distance between two regions j and
k can be the actual number of probes (measurement unit) between them. Here, q is the
decreasing rate of spatial dependence. Common choices for q are 0, 1, 2 (Cressie, 1993). Let
θℓ = (αAℓ , βAℓ,1, . . . , βAℓ,mℓ , γAℓ), where Aℓ is a set of contiguous regions andmℓ is the number
of regions in Aℓ. Then, our full model for a partition A = {Aℓ}
KA
ℓ=1 of {1, . . . ,m}, where KA
denotes the number of clusters, is
pA(x) =
KA∏
ℓ=1
pAℓ(xAℓ ; θℓ), (1)
with
log pAℓ(xAℓ ; θℓ) = αAℓ +
∑
j∈Aℓ
βAℓ,jxj + γAℓ
∑
j<k,j,k∈Aℓ
d˜jkf(xj, xk). (2)
From (1), we know that XAℓ and XAℓ′ are assumed independent for different ℓ and ℓ
′. Denote
the value of xAℓ for sample i = 1, . . . , n by x
i
Aℓ
. Then, we search a partition and parameter
setting that optimizes the following log-likelihood:
(Aˆ, θˆ) = argmax
A∈C,θ
n∑
i=1
∑
Aℓ∈A
log pAℓ(x
i
Aℓ
; θℓ) (3)
where C is the set of contiguous partitions and θ = (θℓ)
KA
ℓ=1. Note that the model (1) contains
an intrinsic trade-off for dividing a cluster into two subclusters: potentially higher likelihood
due to an extra parameter γ (α is not a free parameter) with respect to one cluster versus
potentially lower likelihood due to the forced independency for two regions in a different
subcluster. Which effect prevails depends on how similar the regions between two subclusters
are. As a consequence, the number of clustersKA is not defined a priori, but instead computed
through the optimization step.
Generally, searching the space C for large m is computationally intractable. Therefore, we
restrict the maximum size of a cluster. The components of the product in the right hand side
of (3) are computed in two steps; first, we estimate the parameters of each cluster smaller
than the maximum size. From these parameters, the likelihood of each candidate contiguous
partition can be determined. Second, given the likelihoods, we search the partition space and,
due to the specific partition structure (Cormen et al., 2000), we achieve the global optimum for
the equation (3) by applying Dijkstra’s shortest path algorithm. Note that, from a biological
perspective, a cluster should not cover more than one chromosome, so we apply the algorithm
per chromosome separately.
One could question the usefulness of this cluster algorithm when the results would be
sensitive to similar region-wise differences between, say, two clinical groups. However, observe
from (2) that the likelihood for a given partition Aℓ is to a large extent determined by within-
sample similarity. This means that, as opposed to a p-value type clustering method, our
method is unlikely to cluster two independent consecutive regions that coincidentally have a
similar group difference, because the independence implies that these two differences are likely
to be caused by (partly) different samples. Moreover, in terms of causality, the perception
is that the DNA copy number data (which are early onset markers) potentially affects the
group labels, rather than the other way around. Nevertheless, in rare cases, two independent
consecutive regions may have realizations that coincide for many samples, in particular when
the marginal distributions within groups would (almost) degenerate (e.g. all 0’s in one group
and all 1’s in the other). This may cause coincidental clustering. Therefore, we investigate
how likely such coincidental clustering is for a given data set using a shuffling argument.
Denote the event that a random pair of consecutive regions clusters by E, and the event
that these two regions are dependent due to their genomic proximity by D. Its complement,
lack of genomic dependency, is denoted by D′. If our cluster method performs properly
P (D|E) should be very high. Applying Bayes’ rule, we have
P (D|E) =
P (E|D)P (D)
P (E)
=
P (E|D)P (D)
P (E|D)P (D) + P (E|D′)P (D′)
. (4)
From the data we easily estimate P (E) by counting consecutive pairs of regions that cluster.
Then, if P (E|D′) is very small and P (E) is fairly large, we necessarily have: P (E|D)P (D)≫
P (E|D′)P (D′), which implies P (D|E) ≈ 1. To show that P (E|D′) is small, we break the
genomic dependency structure by shuffling regions such that two regions of the same chromo-
some are not allowed to be neighbors in the shuffled data set. Then, we apply our clustering
method to the shuffled data set. If very few regions cluster, then, necessarily, P (E|D′) is
small. The shuffling is repeated several times to account for the arbitrariness of the shuffling.
Clustering stability
Since a clustering result depends on the data used, especially on the sample size, there exists
uncertainty on the clustering result. We suggest to use the adjusted Rand index (Hubert
and Arabie, 1985) to evaluate stability of the clustering results. If a small change of the
data results in large change of the clustering result, then the clustering method is instable.
Therefore, we check the stability using a cross validation framework.
Suppose regions are numbered from 1 to m and a clustering result is represented as a
contiguous partition of {1, . . . ,m} as in the previous section. Let A = {Aℓ}
KA
ℓ=1 and A
′ =
{A′ℓ′}
KA′
ℓ′=1 be two such partitions which we aim to compare and let |A| be the cardinality of
index subset A. Then the adjusted Rand index (ARI) for the two partitions is defined as
ARI(A,A′) =
r − E(R)
max(R)− E(R)
, r =
KA∑
ℓ=1
KA′∑
ℓ′=1
(
|Aℓ ∩A
′
ℓ′ |
2
)
,
where r is the observed value of random variable R. The expectation of R is computed
conditional on the fixed margins, |Aℓ|, |Aℓ′ |, ℓ = 1, . . . ,KA, ℓ
′ = 1, . . . ,KA′ and the maximum
is computed as the maximum of R regardless of the fixed margins. The adjusted Rand index
takes numbers between −1 to 1.
After obtaining V clustering results from V -fold cross validation, we compute the average
adjusted Rand index, aARI, which serves as our stability measure:
aARI =
1
V
V∑
v=1
ARI(A,A(v)) (5)
where A is the original clustering result from the full data and A(v) is the v-th cross-validated
clustering result.
Hierarchical multiple testing for clusters and regions
Once we have the clusters A = {Aℓ}
KA
ℓ=1, our focus turns to testing association of the region
and cluster-wise data with clinical information. Let us first shortly consider association tests
between groups (reference and test) and states (loss, normal and gain) for a 2×3 contingency
table n = (n11, n12, n13, n21, n22, n23) as Table 1. Let πgs be the population proportion for
group \ state loss normal gain
reference n11 n12 n13 n1+
test n21 n22 n23 n2+
n+1 n+2 n+3 n++
Table 1: Contingency table representation of copy number aberrations between two groups.
group g and state s. Then, for each region j we test
H0j : for any g, s, πgs,j = πg,jπs,j. (6)
For a cluster Aℓ, we simultaneously test
Hℓ0 :
⋂
j∈Aℓ
H0j. (7)
Besides the usual scala of test statistics for a particular testing problem, two classes of
approaches may be distinguished: unconditional and conditional tests. In the first case,
usually only the sample sizes (row margins) are fixed while column margins are variable. In
the second case, both margins are fixed. Permutation tests fall in the latter category, since
these only permute the labels (reference or test) for all samples. Permutation tests are useful
to approximate (summaries of) multivariate distributions, which is exactly what we need for
testing association on the level of clusters. Therefore, we use permutation tests in combination
with the popular Pearson X2 statistic for determining the significance of regions and clusters.
A test statistic for testing (7) is Mℓ = minj∈Aℓ pj, where pj is the p-value obtained for
region j in cluster Aℓ. Using the p-values to define the cluster test statistic standardizes
the regions within a cluster. Before further motivating the use of Mℓ, we first introduce the
hierarchical testing approach.
The hierarchical multiple testing procedure we propose to use for the cluster-region data
is based on that by Meinshausen (2008). Such a procedure allows to test both clusters and
regions within one multiple testing framework. The procedure controls Family-Wise Error
Rate (FWER) for hierarchical hypotheses. Why FWER and not the more popular False
Discovery Rate (FDR)? Firstly, on the level of regions (usually a few hundreds) FDR may
not reflect what it should, because a large ‘cluster’ of highly correlated regions could have a
disproportional large share in the number of discoveries, which highly impacts the estimated
FDR for other regions. This is a consequence of the fact that FDR does not provide control on
subsets (Finner and Roters, 2001). Secondly, our constructed clusters are more independent
than regions, but their number is much lower (often below 100). Then, the power enhancement
of an FDR procedure w.r.t. FWER is usually quite subtle, which may not outbalance the
stronger conclusion one is allowed to draw with FWER control.
The procedure by Meinshausen (2008) assumes an a priori known clustering. Such a
setting can be relevant for these data as well, but often it is preferable to use the same data
for both clustering and testing (see Discussion). In a clustering plus permutation-testing
framework, control of the FWER conditional to the data-based clustering is feasible when
the clustering is permutation invariant: when testing Hℓ0 using permutations, we permute
the clinical responses (group labels Y in our case), while keeping the regions X1:nj fixed for
j ∈ Aℓ. If the result of the cluster algorithm is column-wise permutation invariant, the clusters
may, in the testing phase, be assumed to be known when the null-hypotheses are formulated
conditionally to the clusters. More mathematical details on the validity of permutation tests
in this setting are presented in Appendix II. A similar argument for combining permutation
testing with clustering is given by Goeman and Finos (2010).
The cluster method introduced in this paper is permutation-invariant, because it does
not use the group labels. We use the sequential hierarchical testing procedure proposed by
Goeman and Finos (2010), with critical values that depend on the rejection set R, which
contains both the rejected clusters and regions. This procedure is a slightly more powerful
alternative to the one by Meinshausen (2008). It applies the so-called inheritance principle
in combination with the Shaffer (1986) improvement in an hierarchical testing context. The
inheritance principle is a variation of the fall-back principle (Wiens and Dmitrienko, 2005)
that allows to test an hypothesis less strictly (applying a larger p-value threshold) when
neighboring hypotheses are rejected. Likewise, the Shaffer improvement allows use of a larger
p-value threshold for regions in a cluster, because it uses the connection between the cluster
and region hypotheses: if Hℓ0 is false, at least one H0j should be false too for j ∈ Aℓ (see
Appendix II). We emphasize that this procedure guarantees strong control of FWER (Goeman
and Finos, 2010). It relies only on the individual permutation p-values of clusters and regions.
It is a Holm-type procedure and hence subset pivotality (Dudoit et al., 2003) is not required.
For a given rejection set R (both for clusters in A and regions in {1, ...,m}), critical values
for clusters are defined by αR = α/(KA−DR), where DR equals the number of clusters in R
for which all regions are members of R as well. Note that we opt, as opposed to Meinshausen
(2008), to weigh clusters equally, because for our application small clusters may be as relevant
as large ones. This does not affect control of FWER (see Appendix III for a proof). Critical
values for regions in cluster Aℓ are denoted by αR,ℓ = αR/(|Aℓ| −max(1,DR,ℓ)), where DR,ℓ
equals the number of regions in cluster Aℓ that are members of R.
Then, the hierarchical testing procedure, which is initiated by R = ∅, is as follows.
1. Reject Hℓ0 for cluster Aℓ if P0(Mℓ ≤ mℓ) ≤ αR, where mℓ is the realization of Mℓ.
2. If Hℓ0 is rejected, reject H0j for region j in cluster Aℓ if pj ≤ αR,ℓ.
3. Update the rejection set R and critical values αR,ℓ.
4. Repeat steps 2 and 3 for the non-rejected regions until no more regions are rejected.
5. Update cluster critical values αR.
6. Repeat steps 1 to 5 for the non-rejected clusters and regions therein.
7. Stop when no hypothesis is rejected anymore.
One could argue that for testing clusters Mℓ = minj∈Aℓ pj may have less power than
a statistic that focuses more on ‘average behavior’ (such as a median p-value or a sum of
standardized region-wise test statistics). This is true when small effects add up to one larger
cluster-wise effect, which is quite common in mRNA gene expression studies. However, we
believe the following scenarios to be more relevant for the clustered array CGH data: 1. a
cluster is homogenous (large γ), and hence high positive dependencies between regions within
the cluster are present; 2. a cluster is heterogenous, and for only a few regions the association
exists. It is clear that in the first scenario little power is lost when using min p with respect
to f.e. median p, while in the second scenario median p has less power than min p. Using the
hierarchical testing approach, the latter could, after rejection of Hℓ0, still identify significant
regions in the heterogenous cluster.
Results
We analyze two data sets from Chin et al. (2006) (Data1) and from Douglas et al. (2004)
(Data2). Both data sets have been discretized to ternary values, 0, −1 and 1 (Van de Wiel
et al., 2006). After collapsing, Data1 contains 383 regions in rows and 96 and 49 samples
in columns, which correspond to ER-positive and ER-negative breast cancer samples, re-
spectively. Data2 contains 436 regions in rows and 7 and 30 samples in columns involved
in colorectal cancer, representing two group states: microsatellite instable and chromosomal
instable, respectively.
We first concentrate on the clustering results. For the clustering algorithm, the maximum
number of regions per cluster is constrained to 9, which we generally found to be sufficiently
large. Parameter q, the decreasing rate of spatial dependence is set to 1. Finally, γ is re-scaled
by γ˜ = (eγ − 1)/(eγ +1) so that it lies between −1 to 1 as the nominal correlation coefficient
(equation (6.5.10) in p.430 of Cressie (1993)).
Figures 2 and 3 illustrate the clustering results for Data1 and Data2, respectively. The
number of clusters is 63 and 69, respectively. The 10-fold cross-validation stability score, the
adjusted average Rand index (5), is high for both data sets: 0.969 and 0.963, respectively.
These indicate that the cluster results do not strongly depend on the in- or exclusion of 10%
of the samples.
For both data sets we also investigate the probability on coincidental clustering. More
precisely, we show that for both data sets the probability that two (consecutive) regions in a
cluster are really dependent is high. Following the argument outlined in the Methods section
(see equation (4)) we first need to show that the probability that two consecutive regions
cluster, P (E), is fairly large. Given the relatively small number of clusters in both data sets,
this is the case. Next, we need to show that probability that two independent regions cluster,
P (E|D′), is low by considering shuffled data sets. Indeed, using 25 shuffled data sets, we
observe that for Data 1 (383 regions), on average 382.2 (range: 381-383) clusters are formed,
while for Data 2 (436 regions) on average 434.5 (range: 432-436) clusters are formed. Hence,
we are confident that clusters in the original data sets are almost always created because of
genomic spatial dependency.
For testing association of the class labels with the group labels, 20.000 permutations of
the group labels are performed. The above hierarchical testing procedure was applied to
the clusters and regions. Tables 2 and 3 contain the results of two significant clusters for
both data sets, whereas Figures 4 and 5 combine the overall collapsing, clustering and testing
results. Note that for both data sets the two groups are rather unbalanced. Hence, when a
peak in the differential proportion of either gains or losses is caused by a large proportion of
that aberration in the smaller group, these tend to be less significant (f.e. second cluster on
chromosome 16, Figure 4).
To elucidate the potential benefit of the clusters in a testing setting we compared the
results of the hierarchical testing procedure with a simple Holm step-down procedure applied
to the regions alone. Two FWER cut-offs were considered: α = 0.05 and α = 0.1. Our find-
ings can be summarized as follows. For both data sets and both cut-offs the Holm procedure
only identifies regions that are part of a cluster identified as significant by the hierarchical
procedure. For Data1, α = 0.05, the hierarchical procedure identifies 8 clusters, two of which
contain no regions that are identified by the Holm procedure. Holm identifies 13 regions, hi-
erarchical two extra, 15. For Data1, α = 0.1, the hierarchical procedure identifies 9 clusters,
for which each contains at least one region that is identified by the Holm procedure. Both
procedures identify the same 18 regions. For Data2, α = 0.05, the hierarchical procedure
identifies 1 significant cluster of which none of the regions are identified by Holm. No signifi-
cant regions are identified by both. For Data2, α = 0.1, the hierarchical procedure identifies
3 significant clusters. Two clusters contain not a single significant region according to Holm.
Figure 2: Clustering results for Data1. Losses are plotted in red, normals in black, gains in
green. Clusters are order according to chromosomal position from bottom to top and depicted
alternately in yellow and blue. Sample labels are plotted on the bottom axis, “+” indicates
an ER-positive sample, “-” an ER-negative one.
Figure 3: Clustering results for Data2. See caption Figure 2.
Both Holm and hierarchical identify (the same) one region. In summary, both procedures are
comparable in terms of the number of identified regions, but the hierarchical procedure has
a clear advantage: it is able to identify clusters of which none of the regions are identified
by Holm. Meinshausen (2008) shows similar results using an hierarchical Bonferroni-type
procedure for other data types.
We also compared the hierarchical procedure with a Holm step-down procedure on clusters.
As expected, the number of detections using these procedures differs very little, because
clusters are the highest level in the hierarchy and the proportion of differential clusters is
small.
Discussion
We introduced a conceptual idea for spatial high-dimensional data: dimension reduction in
two steps, collapsing and clustering. These two steps are performed separately: fast collapsing
on all array features and more rigorous, model-based clustering on the resulting regions, much
fewer in number.
Conditional versus unconditional null-hypotheses
The examples presented here require only one data set to be available for the purpose of
both clustering and testing. This implies that the null-hypotheses are conditional on the
clusters. However, the methodology developed here also applies to the unconditional setting,
where the inference is performed on samples independent of those used for clustering. First,
note that since the clustering algorithm always separates chromosomes, the conditional and
unconditional nulls are likely to be very accordant on the chromosome level.
Figure 4: Clustering plus testing, Data1. Chromosomes on the bottom axis, separated by solid
lines. Alternating light-grey and white bars demarcate clusters. Crosses show the association
coefficients γ˜ (scale on left axis). Dark-grey bars: significant clusters, tick marks at the top
axis: significant regions (α = 0.1). Bottom plot: absolute difference between proportions of
gains in the two groups (green) and between proportions of losses (red) (scale on right axis).
Figure 5: Clustering plus testing, Data2. See caption Figure 4.
Table 2: Comparison of p-values for two clusters in Data1. Columns 2-4 and 7-9 denote the
raw (unadjusted), Holm and hierarchical p-values for clusters and regions, respectively. Fifth
column contains the association coefficient γ˜.
Clust. p clust. p clust. p clust. γ˜ Reg. p reg. p reg. p reg.
raw Holm Hier. raw Holm Hier.
6 0.0006 0.0366 0.0402 0.4653 1 0.0058 1.0000 1.0000
6 0.0006 0.0366 0.0402 0.4653 2 0.0076 1.0000 1.0000
6 0.0006 0.0366 0.0402 0.4653 3 0.0023 0.8004 0.9246
6 0.0006 0.0366 0.0402 0.4653 4 0.0007 0.2541 0.3283
6 0.0006 0.0366 0.0402 0.4653 5 0.0002 0.0738 0.0938
6 0.0006 0.0366 0.0402 0.4653 6 0.0403 1.0000 1.0000
6 0.0006 0.0366 0.0402 0.4653 7 0.2804 1.0000 1.0000
6 0.0006 0.0366 0.0402 0.4653 8 0.1696 1.0000 1.0000
16 0.0000 0.0000 0.0000 0.7999 1 0.0034 1.0000 0.2245
16 0.0000 0.0000 0.0000 0.7999 2 0.0009 0.3060 0.1139
16 0.0000 0.0000 0.0000 0.7999 3 0.0000 0.0000 0.0000
16 0.0000 0.0000 0.0000 0.7999 4 0.0000 0.0000 0.0000
16 0.0000 0.0000 0.0000 0.7999 5 0.0001 0.0374 0.0268
16 0.0000 0.0000 0.0000 0.7999 6 0.0001 0.0374 0.0268
16 0.0000 0.0000 0.0000 0.7999 7 0.0001 0.0189 0.0201
16 0.0000 0.0000 0.0000 0.7999 8 0.0001 0.0189 0.0201
Table 3: Comparison of p-values for two clusters in Data2. See caption Table 2.
Clust. p clust. p clust. p clust. γ˜ Reg. p reg. p reg. p reg.
raw Holm Hier. raw Holm Hier.
66 0.0013 0.0863 0.0875 0.7076 1 0.0006 0.2371 0.1925
66 0.0013 0.0863 0.0875 0.7076 2 0.0065 1.0000 0.9030
66 0.0013 0.0863 0.0875 0.7076 3 0.0017 0.7174 0.3570
66 0.0013 0.0863 0.0875 0.7076 4 0.0012 0.4888 0.3220
66 0.0013 0.0863 0.0875 0.7076 5 0.0007 0.3010 0.2450
66 0.0013 0.0863 0.0875 0.7076 6 0.0112 1.0000 0.9030
68 0.0007 0.0455 0.0455 0.5499 1 0.0336 1.0000 1.0000
68 0.0007 0.0455 0.0455 0.5499 2 0.0387 1.0000 1.0000
68 0.0007 0.0455 0.0455 0.5499 3 0.0132 1.0000 1.0000
68 0.0007 0.0455 0.0455 0.5499 4 0.0119 1.0000 1.0000
68 0.0007 0.0455 0.0455 0.5499 5 0.0160 1.0000 1.0000
68 0.0007 0.0455 0.0455 0.5499 6 0.0052 1.0000 1.0000
68 0.0007 0.0455 0.0455 0.5499 7 0.0002 0.0654 0.0630
In the conditional setting, we emphasize that the FWER on clusters estimated from
the same data is well-defined, albeit from conditional, and hence random, null hypotheses
(because the clusters are random). This point of view was investigated by Perone Pacifico
et al. (2004) in the context of a clustered version of FDR. However, as opposed to approach
of Perone Pacifico et al. (2004) using p-value-based clustering, we argue that the conditional
approach introduced here clearly delineates the information in the data which is used to make
clusters from the information used to perform testing on the clusters, because the clusters
are permutation invariant, so that we obtain an interpretable procedure on the permutation
probability space as well.
We acknowledge that the conditional setting is not fully in accordance with the traditional
hypothesis testing setting, which is why one might prefer the unconditional setting in some
cases. Reasons why we emphasize the conditional setting are the following. Tumor array CGH
is still very expensive, and, more importantly, for many clinical studies it is not practically
feasible to obtain good quality tumor material for a large amount of samples. Moreover, cancer
is a very heterogeneous disease, and hence the power to detect differences between groups for
particular genomic locations is likely to be small for small sample sizes. For example, some
aberrations occur in only 5% of the entire population, but it may still be relevant to detect
such an aberration when (most of) it 5% would belong to one group. Therefore, one often
prefers to use as many samples as possible in the testing phase, and not ‘sacrifice’ samples for
the purpose of clustering. However, the unconditional setting may be particularly attractive
when aCGH data (X) is externally available, but the response (Y ) is not. In such a case, the
external data can anyhow not be used in the testing phase. Our software easily applies to
such a setting as well.
Finally, we studied to what extent the results of the conditional and unconditional ap-
proaches differ for Data1. We repeatedly split this data set in two parts. The conditional
approach uses the second part for both clustering and testing, whereas the unconditional
approach uses the first part for clustering and the second for testing. We registered which
regions are significant and which regions are a member of a significant cluster, at α = 0.2.
Summarizing, on average 94.3% (99.9%) of the regions rejected (non-rejected) by the con-
ditional approach were confirmed by the unconditional approach, whereas on average 93.2%
(99.8%) of the regions that are member of a rejected (non-rejected) cluster as determined by
the conditional approach were confirmed by the unconditional approach. Hence, it is com-
fortable to notice that the stability of the clustering implies a high agreement between the
unconditional and conditional approach, whereas the latter uses only half of the data.
Other issues and conclusion
A byproduct of our clustering method is the strength measure of association (γ) within a
cluster. This helps in interpreting the results of the hierarchical multiple testing on clusters
and regions: if γ is relatively small for a significant cluster, one expects that the significance
is driven by a few regions within the cluster, which should be reflected in the adjusted region-
wise p-values. For large values of γ one expects rather similar adjusted region-wise p-values.
Hence, to some extent γ and the region-wise p-values may help in distinguishing genomic
regions that are potentially causally related to the response and those that are just correlated
with neighboring, more strongly associated regions. In any case, further biological validation,
also at other molecular levels, such as mRNA or protein, is needed to decide which genomic
DNA regions are really causally related to the response.
Some prefer the use of undiscretized rather than discretized array CGH data for testing
association with clinical information. We believe our cluster-testing approach to be useful
in this setting as well. The clustering would then group features that share the underlying
discrete characteristics of the data, while the corresponding undiscretized data would be used
to achieve (supposedly) more power in the permutation testing procedure.
For clusters that contain regions that are amplified (high copy number gain) rather than
gained, one could apply our algorithm on a 4-digit code (-1,0,1,2) but this may be very time-
consuming. When few losses (-1) are present in such a cluster (which is not unlikely given
the presence of amplifications), one may locally re-define the 4-digit code to a 3-digit one
where the losses and normals would be joined in one class. Another alternative solution is
to keep the 4-digit code, but instead of using an extra parameter in model (1) use the same
parameter as for xi = 1 (gains), but now with xi = 2. This would give more weight to two
consecutively amplified regions than for two consecutively gained regions. Double deletions
may be dealt with in a similar way.
Our clustering algorithm suggests a development for DNA probe design in low dimen-
sional platforms such as MLPA (Schouten et al., 2002). If strongly associated clusters could
be verified in further studies, then one may consider to use only one MLPA probe per cluster.
Such low dimensional platforms are usually less costly, more reproducible and more straight-
forward to analyze. Another application of our genomic clusters is the clustering of samples
and prediction of clinical outcome. Van Wieringen et al. (2008) show that use of genomic
regions rather than individual probes to cluster samples based on array CGH data enhances
clustering performance. In prediction, the smaller number of clusters may result in simpler
and more robust feature selection.
In summary, we developed a dedicated clustering algorithm which, in combination with
permutation testing, allows a multiple resolution perspective on association of array CGH
data with clinical information. With the introduction of extremely high-resolution data, f.e.
obtained by massive parallel sequencing, the need for such methods will only increase.
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Appendix I: Software
The methods discussed here, both for clustering and hierarchical testing, are implemented
in the R-package dnaCplusT. The package contains example data sets, documentation on
functions and parameters and the actual R-code. For the implementation of the procedures,
we used R-Bioconductor software packages RBGL, partitions and multtest. The package is
available from the last author’s web site: http://www.few.vu.nl/∼mavdwiel/dnaCplusT.html.
Appendix II: Validity of permutation test
Here, we prove the validity of the permutation tests in our setting. In this section, let us
write Xj = X
1:n
j for short. Under the null
H0,j: Y and Xj are independent conditionally on Â(X) = A,
the following proves that the distribution of (Y,Xj) is equal to the distribution of (Y
σ,Xj),
conditionally on Â(X) = A, for any deterministic permutation σ of {1, ..., n} (where the
superscript “σ” codes for a σ-column-wise permutation of the vector or of the matrix):
P(Y = yσ,Xj = xj |Â(X) = A)
= P(Y = yσ|Â(X) = A)P(Xj = xj |Â(X) = A)
= P(Y σ = yσ|Â(Xσ) = A)P(Xj = xj|Â(X) = A)
= P(Y σ = yσ|Â(X) = A)P(Xj = xj |Â(X) = A)
= P(Y = y|Â(X) = A)P(Xj = xj |Â(X) = A)
= P(Y = y,Xj = xj|Â(X) = A).
Similarly, we may prove that under the null
Hℓ0: Y and (Xj)j∈Aℓ are independent conditionally on Â(X) = A, (8)
the distribution of (Y, (Xj)j∈Aℓ) is equal to the distribution of (Y
σ, (Xj)j∈Aℓ), conditionally
on Â(X) = A, for any deterministic permutation σ of {1, ..., n}.
Null-hypothesis (8) is sufficient for applying permutation and allows for FWER control
using the inheritance principle. However, in order the sharpen FWER control using Shaffer’s
(1986) improvement, we need to assume that (8) is implied by⋂
j∈Aℓ
H0,j,
because the intersection hypothesis contains the logical relationship between the region-wise
null-hypotheses and the cluster hypothesis needed to apply this improvement. This assump-
tion means that the dependency between Y and the vector (Xj)j∈Aℓ is fully described by
dependencies between Y and Xj ’s, j ∈ Aℓ. So for example (Y ⊥ X1) ∧ (Y ⊥ X2) ⇒ Y ⊥
(X1,X2). Note the similarity between this assumption and one often made in step-wise regres-
sion (with random covariates), where an interaction term X1X2 (which models dependency
between Y and (X1,X2)) is only considered once at least one of the main terms (X1 or X2)
is present in the model.
Appendix III: Proof of FWER control
Here, we provide a proof that the hierarchical multiple testing R controls the FWER both
on the cluster and on the region levels. We consider the case where we include the Shaffer
correction (the other case is similar). The proof was provided in Goeman and Finos (2010),
but for a different type of hypothesis weighting. Our arguments are very similar.
The proof uses the so-called “sequential rejection principle, presented by Goeman and
Solari (2009) (see also Arlot et al. (2010)). Our hierarchical rejection procedure R, rejecting
both clusters A ∈ A and regions j ∈ A, can be expressed as the following sequential rejective
procedure: R = Rk where R0 = ∅ and for all i ≥ 0,
Ri+1 = Ri ∪ {A ∈ A|pA ≤ αRi} ∪
⋃
A∈A
{j ∈ A|pj ≤ αRi,A},
and where k is the first i ≥ 0 for which Ri+1 = Ri. In the above recursion relation, pA and
pj are the p-values for cluster A and region j, respectively, while the threshold on clusters
is αR = α/(KA − |ER|), with ER = {A ∈ R ∩ A|A ⊂ R}, and the threshold on regions
is αR,A = αR1{A ∈ A ∩R}/(|A| − max(1, |A ∩ R|)). In the latter thresholds, we use the
convention 1/0 = +∞ and 0/0 = 0.
We aim to establish that our procedure controls the hierarchical FWER at a pre-specified
level α. From the sequential rejection principle, the latter is true, as soon as both a “mono-
tonicity condition” and a “single step condition” hold (Goeman and Solari, 2009). The first
condition is satisfied because αR and αR,A are nondecreasing in R. The second condition is
satisfied if we have ∑
A∈A∩H0
αHc
0
+
∑
A∈A
∑
j∈A∩H0
αHc
0
,A ≤ α, (9)
where we denoted by H0 the set of the true clusters and regions and by H
c
0 its complementary.
We now prove (9): we have
∑
A∈A
∑
j∈A∩H0
αHc
0
,A = αHc
0
∑
A∈A∩Hc
0
|A ∩H0|
|A| −max(1, |A ∩Hc0|)
.
Now, the sum appearing in the right hand side of the above relation can be taken only over
A ∈ A ∩ Hc0 such that |A ∩ H0| 6= 0, that is over A ∈ A ∩ H
c
0\EHc0 . Moreover, we may use
the logical relation between the hierarchical hypotheses saying that if a cluster is false then
at least one of its regions is false: A ∈ A ∩ Hc0 implies |A ∩ H0| ≤ |A| − 1. Combining these
two facts, we obtain
∑
A∈A
∑
j∈A∩H0
αHc
0
,A = αHc
0
∑
A∩Hc
0
\EHc
0
|A ∩H0|
|A| −max(1, |A ∩Hc0|)
≤ αHc
0
∑
A∩Hc
0
\EHc
0
min(|A ∩H0|, |A| − 1)
|A| −max(1, |A ∩Hc0|)
= αHc
0
(|A ∩ Hc0| − |EHc0 |)
Thus, we have∑
A∈A∩H0
αHc
0
+
∑
A∈A
∑
j∈A∩H0
αHc
0
,A ≤ αHc
0
(|A ∩H0|+ |A ∩ H
c
0| − |EHc0 |)
= αHc
0
(KA − |EHc
0
|) = α,
which proves (9) and the required FWER control.
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